South Africa - 2023 - Health

Updated-Rifampicin Resistant-TB-Clinical-Guidelines 2023

Ministry of Health

Introduces shorter 6-month regimens (BPaL and BPaL-L), updated eligibility criteria, and enhanced monitoring protocols to improve RR-TB treatment outcomes and reduce loss to follow-up

Request Expert Analysis

Ask one of our policy analysts to take an in-depth look at this policy and provide you with a written summary. An additional cost may apply. Please let us know what questions you are looking to answer.

Thank you for requesting an expert analysis

A member of our team will review your request and reply back to the email address on file.